Collagen Hybridizing Peptides Conjugated to Water-Soluble Copolymers for Targeting Intratibial Osteosarcoma
0 Comments
Discover innovative strategies for treating osteosarcoma (OS) with localized drug delivery using Collagen Hybridizing Peptides (CHPs). OS, a malignant bone cancer, often requires surgery and chemotherapy, but these treatments are plagued by systemic side effects. This research highlights the potential of CHPs to selectively target tumors by binding to damaged collagen in bone tissue.
View Details